Oncology Institute (DFPH) Short term Debt (2020 - 2021)

Oncology Institute (DFPH) reported Short term Debt of $183000.0 for Q4 2021, down 96.59% on a YoY basis from $5.4 million in Q4 2020, and down 96.59% quarter-over-quarter from $5.4 million in Q4 2020.

Oncology Institute (DFPH) Short term Debt (2020 - 2021) Analysis & Trends

Oncology Institute has reported Short term Debt for 2 years, with the latest figure at $183000.0 in Q4 2021.

  • For the quarter ending Q4 2021, Short term Debt fell 96.59% year-over-year to $183000.0; the trailing twelve-month figure through Dec 2021 stood at $183000.0 (down 96.59% YoY), and the FY2021 full-year result was $183000.0, down 96.59% from the prior year.
  • Short term Debt for Q4 2021 stood at $183000.0, down from $5.4 million in the prior quarter.
  • The five-year high for Short term Debt was $5.4 million in Q4 2020, with the low at $183000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn
10 Oncology Institute - - 139.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 183,000.00
Dec 31, 2020 5.37 Mn